Published in Biochem Biophys Res Commun on July 05, 1999
Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol (2003) 8.12
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev (2002) 7.08
Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J (2000) 4.85
Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J Biol Chem (2002) 2.59
Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci U S A (2000) 1.82
Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Mol Cell Biol (2002) 1.67
MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem (2003) 1.66
Redox regulation of mitochondrial function. Antioxid Redox Signal (2012) 1.34
Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum Reprod Update (2009) 1.29
Signal transduction. How do cells sense oxygen? Science (2001) 1.27
Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J Biol Chem (2001) 1.26
Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium. J Biol Chem (2009) 1.12
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis. Proc Natl Acad Sci U S A (2002) 1.11
Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol (2012) 1.05
Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases. Curr Drug Targets (2013) 1.01
Role of pancreatic stellate cells in chemoresistance in pancreatic cancer. Front Physiol (2014) 1.00
Hypoxia inducible factor-1 as a target for neurodegenerative diseases. Curr Med Chem (2011) 0.91
Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Clin Exp Metastasis (2006) 0.91
Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow. J Immunol (2009) 0.89
Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies. Biomed Res Int (2015) 0.89
Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships. Free Radic Biol Med (2014) 0.83
A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level. EMBO J (2015) 0.80
Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists. Can Urol Assoc J (2007) 0.78
Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis. Mediators Inflamm (2015) 0.78
The Tumorigenic Roles of the Cellular REDOX Regulatory Systems. Oxid Med Cell Longev (2015) 0.77
The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe. Sci Rep (2015) 0.77
Prolyl 4 hydroxylase: a critical target in the pathophysiology of diseases. Korean J Physiol Pharmacol (2013) 0.75
The expression of hypoxia-inducible factor-1α gene is not affected by low-oxygen conditions in yellow perch (Perca flavescens) juveniles. Fish Physiol Biochem (2017) 0.75
Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem (1997) 7.67
Enhancer element at the 3'-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J Biol Chem (1991) 2.55
Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure. Blood (1989) 2.41
Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest (1994) 2.10
Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol (1997) 2.08
An approach to probe some neural systems interaction by functional MRI at neural time scale down to milliseconds. Proc Natl Acad Sci U S A (2000) 1.75
Physiologic regulation and tissue localization of renal erythropoietin messenger RNA. Blood (1987) 1.70
Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med (1996) 1.69
Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J (2000) 1.66
Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res (1994) 1.58
Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1beta and TNFalpha. Invest Ophthalmol Vis Sci (2000) 1.51
Functional mapping in the human brain using high magnetic fields. Philos Trans R Soc Lond B Biol Sci (1999) 1.47
International economic analysis of primary prevention of cardiovascular disease with pravastatin in WOSCOPS. West of Scotland Coronary Prevention Study. Eur Heart J (1999) 1.46
Transport spectroscopy of a single dopant in a gated silicon nanowire. Phys Rev Lett (2006) 1.46
Functional activation in motor cortex reflects the direction and the degree of handedness. Proc Natl Acad Sci U S A (1997) 1.44
Enhancement by hypoxia of human erythropoietin gene transcription in vitro. J Biol Chem (1990) 1.39
Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch Biochem Biophys (1996) 1.35
Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J Biol Chem (2001) 1.26
Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood (1989) 1.25
Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc Natl Acad Sci U S A (1993) 1.17
Does electronic implementation of questionnaires used in asthma alter responses compared to paper implementation? Qual Life Res (2001) 1.15
Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med (1979) 1.12
Increase of creatine kinase activity in the visual cortex of human brain during visual stimulation: a 31P magnetization transfer study. Magn Reson Med (1997) 1.12
General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia-inducible factor 1alpha. FASEB J (1999) 1.12
Streptimonospora salina gen. nov., sp. nov., a new member of the family Nocardiopsaceae. Int J Syst Evol Microbiol (2001) 1.11
Magnetic resonance studies of brain function and neurochemistry. Annu Rev Biomed Eng (2000) 1.11
Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha. Proc Natl Acad Sci U S A (1999) 1.10
Treating acetaminophen overdose: thresholds, costs and uncertainties. Clin Toxicol (Phila) (2013) 1.10
Genetics of drought tolerance during seed germination in tomato: inheritance and QTL mapping. Genome (2003) 1.08
Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using (1)H-[(13)C] MRS and fMRI. Magn Reson Med (2001) 1.08
Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity (1994) 1.08
The effect of stimulus-response compatibility on cortical motor activation. Neuroimage (2001) 1.07
Renal and extrarenal erythropoietin production in anaemic rats. Br J Haematol (1980) 1.07
The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res (1997) 1.07
Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Hepatology (1997) 1.06
Biologic and immunologic erythropoietin in extracts from hypoxic whole rat kidneys and in their glomerular and tubular fractions. J Lab Clin Med (1984) 1.05
The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood (1991) 1.04
Increased ferritin synthesis and iron uptake in inflammatory mouse macrophages. Scand J Haematol (1984) 1.03
Airways obstruction in pulmonary tuberculosis. Scand J Respir Dis (1966) 1.02
"Erythrocytosis" in renal transplantation patients treated with cyclosporine. Transplant Proc (1988) 1.02
Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anaemia and the effect of anti-inflammatory treatment. Br J Haematol (1987) 1.02
Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol (1996) 1.02
Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors. Biochimie (2005) 1.00
Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med (1987) 1.00
Complex role of protein phosphorylation in gene activation by hypoxia. Kidney Int (1997) 0.99
Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men. Clin Pharmacol Ther (1990) 0.99
Plasma erythropoietin in health and disease. Ann Clin Lab Sci (1980) 0.99
Retinotopic mapping of lateral geniculate nucleus in humans using functional magnetic resonance imaging. Proc Natl Acad Sci U S A (1999) 0.98
Physiologic and molecular biology of erythropoietin. Med Oncol Tumor Pharmacother (1986) 0.98
Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem (2000) 0.98
NMR studies of 1H NOEs in glycogen. Biochemistry (1993) 0.98
Mapping of lateral geniculate nucleus activation during visual stimulation in human brain using fMRI. Magn Reson Med (1998) 0.97
A case-control study of risk factors for large bowel carcinoma. Cancer (1983) 0.95
Human primary visual cortex and lateral geniculate nucleus activation during visual imagery. Neuroreport (1998) 0.94
Retracted Hypoxia-inducible factor 1alpha (HIF-1alpha) is a non-heme iron protein. Implications for oxygen sensing. J Biol Chem (1998) 0.94
Allelic variation of polyphenol oxidase (PPO) genes located on chromosomes 2A and 2D and development of functional markers for the PPO genes in common wheat. Theor Appl Genet (2007) 0.93
Strategies for the management of hypercholesterolaemia: a systematic review of the cost-effectiveness literature. J Health Serv Res Policy (1997) 0.93
Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer. J Cancer Res Clin Oncol (2014) 0.91
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas. Am J Pathol (1999) 0.91
Nuclear magnetic resonance relaxation of glycogen H1 in solution. Biochemistry (1993) 0.90
Activation of heat-shock transcription factor by graded reductions in renal ATP, in vivo, in the rat. J Clin Invest (1994) 0.90
Risk of large-bowel cancer in synthetic fiber manufacture. Cancer (1984) 0.89
Secondary erythrocytosis due to a cerebellar hemangioblastoma: demonstration of erythropoietin mRNA in the tumor. Blood (1991) 0.89
Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration. J Am Soc Nephrol (1992) 0.89
Determination of deoxymyoglobin changes during graded myocardial ischemia: an in vivo 1H NMR spectroscopy study. Magn Reson Med (1997) 0.89
Effects of movement predictability on cortical motor activation. Neurosci Res (1998) 0.89
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family overexpression in human lung tumor. Ukr Biokhim Zh (1999) (2005) 0.89
Identification and pathogenicity of Vibrio ponticus affecting cultured Japanese sea bass, Lateolabrax japonicus (Cuvier in Cuvier and Valenciennes). Lett Appl Microbiol (2007) 0.88
Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice. Am J Physiol (1997) 0.87
Cytokine gene expression in splenic macrophages and Kupffer cells following haemorrhage. Cytokine (1995) 0.87
Spatial and temporal differentiation of fMRI BOLD response in primary visual cortex of human brain during sustained visual simulation. Magn Reson Med (1998) 0.87
No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus. Hum Immunol (1996) 0.86
Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha-hydroxylase gene. Proc Natl Acad Sci U S A (1999) 0.86
Cellular sites of extrarenal and renal erythropoietin production in anaemic rats. Br J Haematol (1992) 0.86
Erythropoietin in liver tissue extracts and in liver perfusates from hypoxic rats. Am J Physiol (1983) 0.86
Are the native kidneys responsible for erythrocytosis in renal allorecipients? Transplantation (1979) 0.86
Erythropoietin production in response to anemia or hypoxia in the newborn rat. Blood (1982) 0.84
Inappropriate increase in erythropoietin titers during chemotherapy. Am J Hematol (1989) 0.83
Spatial distribution of tissue inhibitor of metalloproteinase-1 mRNA in chronic liver disease. J Hepatol (1999) 0.83
Identification and validation of QTLs for salt tolerance during vegetative growth in tomato by selective genotyping. Genome (2001) 0.83
Correlation of activation sizes between lateral geniculate nucleus and primary visual cortex in humans. Magn Reson Med (2001) 0.82
HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum Immunol (1995) 0.82
Effect of oxygen content on the transport properties of LaTiO(3+β/2) thin films. J Phys Condens Matter (2006) 0.82
Endoscopic ultrasonography assessment for ampullary and bile duct malignancy. Diagn Ther Endosc (1996) 0.82
Dynamics of erythropoiesis following renal transplantation. Kidney Int (1987) 0.82
Anti-herpes virus activity of Solanum steroidal glycosides. Biol Pharm Bull (2000) 0.81
Zeolite membranes - a review and comparison with MOFs. Chem Soc Rev (2015) 0.81
Circulating erythropoietin in patients with myelodysplastic syndromes. Br J Haematol (1989) 0.81
Detecting natural abundance carbon signal of NAA metabolite within 12-cm3 localized volume of human brain using 1H-[13C] NMR spectroscopy. Magn Reson Med (1998) 0.81
SU-8 microprobe with microelectrodes for monitoring electrical impedance in living tissues. Biosens Bioelectron (2008) 0.81
Characterization of metallothioneins (MT-I and MT-II) in the yak. J Anim Sci (2006) 0.81
Parallel stranded DNA under the scanning tunnelling microscope. Biochim Biophys Acta (1992) 0.81
The collisional hypothesis of insulin action, receptor internalization and diabetes. Trends Biochem Sci (1989) 0.81
Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis: the role of erythropoietin. Am J Med (1982) 0.81
The survival and value of liver transplantation for liver carcinoma: a single-center experience. Transplant Proc (2004) 0.80
Erythropoietin: from mountain top to bedside. Adv Exp Med Biol (1989) 0.80
Assessment of the association between blood pressure control and health care resource use. Clin Ther (2001) 0.80
Lunar phases, myocardial infarction and hemorrheological character. A Western medical study combined with appraisal of the related traditional Chinese medical theory. Chin Med J (Engl) (1989) 0.80